Edmund Dunn

Insider Reports History

Entity
Individual
Location
Monte Rosa Therapeutics, Inc., 321 Harrison Avenue, Suite 900, Boston, MA
Signature
/s/ Phil Nickson, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Edmund Dunn:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Monte Rosa Therapeutics, Inc. Principal Accounting Officer Common Stock 13.9K $53.4K $3.83 Jul 5, 2024 Direct
Monte Rosa Therapeutics, Inc. Principal Accounting Officer Stock Option (Right to Buy) 35.9K Jan 2, 2024 Direct

Insider Reports Filed by Edmund Dunn

Symbol Company Period Transactions Value $ Form Type Date Filed Role
GLUE Monte Rosa Therapeutics, Inc. Jul 5, 2024 1 -$6.17K 4 Jul 9, 2024 Principal Accounting Officer
GLUE Monte Rosa Therapeutics, Inc. Jun 3, 2024 1 -$4.88K 4 Jun 5, 2024 Principal Accounting Officer
GLUE Monte Rosa Therapeutics, Inc. Jan 2, 2024 2 $0 4 Jan 4, 2024 Principal Accounting Officer
GLUE Monte Rosa Therapeutics, Inc. Aug 8, 2023 0 $0 3 Aug 18, 2023 Principal Accounting Officer